Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 151514
                    [Title] => Drugs beyond our reach
                    [Summary] => Viagra, the drug for erectile dysfunction, must be doing wonders – in terms of efficacy and Pfizer’s sales. After enjoying a few years’ lead, Viagra will soon face stiff competition from the Bayer group. This September Bayer is launching in the United States its version of Viagra. The drug, vardenafil, will be marketed as Nuviva, and it will be introduced in the Philippines in September next year.


                    [DatePublished] => 2002-02-22 00:00:00
                    [ColumnID] => 133252
                    [Focus] => 0
                    [AuthorID] => 1807094
                    [AuthorName] => Ana Marie Pamintuan
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

KANTI

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 151514
                    [Title] => Drugs beyond our reach
                    [Summary] => Viagra, the drug for erectile dysfunction, must be doing wonders – in terms of efficacy and Pfizer’s sales. After enjoying a few years’ lead, Viagra will soon face stiff competition from the Bayer group. This September Bayer is launching in the United States its version of Viagra. The drug, vardenafil, will be marketed as Nuviva, and it will be introduced in the Philippines in September next year.


                    [DatePublished] => 2002-02-22 00:00:00
                    [ColumnID] => 133252
                    [Focus] => 0
                    [AuthorID] => 1807094
                    [AuthorName] => Ana Marie Pamintuan
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Drugs beyond our reach

By SKETCHES | By Ana Marie Pamintuan | February 22, 2002 - 12:00am

Viagra, the drug for erectile dysfunction, must be doing wonders – in terms of efficacy and Pfizer’s sales. After enjoying a few years’ lead, Viagra will soon face stiff competition from the Bayer...

Opinion